Avian Antibodies Can Eliminate Interference Due to Complement Activation in ELISA

Upsala Journal of Medical Sciences

Volumn 106, Issue 3, 2001, Pages 189-195

  Carlander, D ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOVINE SERUM ALBUMIN;

ANIMAL; ARTICLE; CHICKEN; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GOAT; HUMAN; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES; CHICKENS; COMPLEMENT ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOATS; HUMANS; SERUM ALBUMIN, BOVINE;

EID: 0035552381     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-145     Document Type: Article

References (17)

1. Baatrup, G., Svehag, S. E. & Jensenius, J. C. The attachment of serum and plasma derived C3 to solid phase immune aggregates and its relation to complement-mediated solubilization of immune complexes. Scand. J. Immunol., 23: 397-406, 1986.
2. Campbell, R. D., Dodds, A. W. & Porter, R. R. The binding of human complement component C4 to antibody-antigen aggregates. Biochem. J., 189: 67-80, 1980.
3. Hilborne, L., Lee, H.& Cathcart, P. STAT testing? A guideline for meeting clinician turnaround time requirements. Practice parameter. Am. J. Clin. Pathol., 105: 671-675, 1996.
4. Kapyaho, K., Tanner, P. & Weber, T. Effect of complement binding on a solid-phase immunometric TSH assay. Scand. J. Clin. Lab Invest, 49: 211-215, 1989.
5. Kricka, L. J. Human anti-animal antibody interferences in immunological assays. Clin. Chem., 45: 942-956, 1999.
6. Larsson, A. & Sjoquist, J. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA. J. Immunol. Methods, 119: 103-109, 1989.
7. Larsson, A., Wejaker, P. E., Forsberg, P. O. & Lindahl, T. Chicken antibodies: a tool to avoid interference by complement activation in ELISA. J. Immunol. Methods, 156: 79-83, 1992.
8. Liszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A. & Atkinson, J. P. Control of the complement system. Adv. Immunol., 61: 201-283, 1996.
9. Nilsson, B., Nilsson, U. R., Karlsson-Parra, A., Sjolin-Forsberg, G. & Hallgren, R. Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunction. Ann. Rheum. Dis., 53: 691-694, 1994.
10. Nilsson, U. R., Storm, K. E., Elwing, H. & Nilsson, B. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. Mol. Immunol., 30: 211-219, 1993.
11. Sanchez-Cuenca, J. M. Complement mediated solubilization: role of the complement in the clearance of circulating immune-complexes. Allergol. Immunopathol. (Madr. ), 22: 197-203, 1994.
12. Walport, M. J. Complement. First of two parts. N. Engl. J. Med., 344: 1058-1066, 2001.
13. Walport, M. J. Complement. Second of two parts. N. Engl. J. Med., 344: 1140-1144, 2001.
14. Weber, T. H., Kapyaho, K. I. & Tanner, P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand. J. Clin. Lab Invest Suppl, 201: 77-82, 1990.
15. Whaley, K. & Ahmed, A. E. Control of immune complexes by the classical pathway. Behring Inst. Mitt., 111-120, 1989.
16. Zimmermann-Nielsen, E., Svehag, S. E., Thorlacius-Ussing, O. & Baatrup, G. ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes. J. Immunol. Methods, 249: 43-51, 2001.
17. Zwirner, J., Wittig, A., Kremmer, E. & Gotze, O. A novel ELISA for the evaluation of the classical pathway of complement. J. Immunol. Methods, 211: 183-190, 1998.